JPRN-UMIN000022989已完成未知
Comparative study of once vs. twice daily regimen of double dose of rabeprazole in uncontrolled GERD patients taking usual dose of proton pump inhibitors. - Once vs. twice daily regimen of double dose PPI in GERD
Keiyu Hospital Internal Medicine0 个研究点目标入组 100 人开始时间: 2016年7月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 89years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects who have any mental disorders Subjects who have histories of allergy against laperazol Subjects who have serious complications and problems to continue to perform this clinical trial Subjects who are pregnant, possibly pregnant, or feeding her children Subjects who cannot accept an upper GI endoscopic examination Subjects who have two-fold dose of PPI during 4 weeks before the clinical trial starts Subjects who are decided to be unacceptable for this clinical trial by their clinical physicians
研究者
相似试验
尚未招募
4 期
Glargine once versus twice dailyCTRI/2023/10/059275surbhi bharti
已完成
2 期
Comparison of the effect of single and twice daily administration of ranitidine in relief of morning abdominal pain and nausea in childreabdominal pain and nausea.Unspecified abdominal painIRCT20171211037830N2Deputy of Research of Golestan University of Medical Sciences150
进行中（未招募）
不适用
Effects and comparisons of once & twice daily insulin’s in combination with oral hypoglycaemic agents on glycaemic control, hypoglycaemia and weight in type 2 Diabetes.MedDRA version: 8.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusType 2 DiabetesEUCTR2005-003824-21-GBRoyal Liverpool University Hospital
已完成
4 期
Once-Daily Asenapine for SchizophreniaSchizophreniaNCT01549041Duke University30
已完成
4 期
Efficacy of once daily versus divided daily administration of low daily dosage (15 mg/day) of methimazole in the induction of euthyroidism in Graves' hyperthyroidism: A randomized controlled studyGraves’ hyperthyroidismGraves’ hyperthyroidism,once daily methimazole administration,induction of euthyroidismTCTR20170529001one55